These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 10764590)
1. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation. Johnson BA; Wilson EM; Li Y; Moller DE; Smith RG; Zhou G J Mol Biol; 2000 Apr; 298(2):187-94. PubMed ID: 10764590 [TBL] [Abstract][Full Text] [Related]
3. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity. Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614 [TBL] [Abstract][Full Text] [Related]
4. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Xu HE; Stanley TB; Montana VG; Lambert MH; Shearer BG; Cobb JE; McKee DD; Galardi CM; Plunket KD; Nolte RT; Parks DJ; Moore JT; Kliewer SA; Willson TM; Stimmel JB Nature; 2002 Feb; 415(6873):813-7. PubMed ID: 11845213 [TBL] [Abstract][Full Text] [Related]
5. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the human LRH-1 DBD-DNA complex reveals Ftz-F1 domain positioning is required for receptor activity. Solomon IH; Hager JM; Safi R; McDonnell DP; Redinbo MR; Ortlund EA J Mol Biol; 2005 Dec; 354(5):1091-102. PubMed ID: 16289203 [TBL] [Abstract][Full Text] [Related]
8. Expression, purification, and initial structural characterization of rat orphan nuclear receptor NOR-1 LBD domain. Razzera G; Vernal J; Portugal RV; Calgaro MR; Fernandez P; Zakin MM; Polikarpov I; Terenzi H Protein Expr Purif; 2004 Oct; 37(2):443-9. PubMed ID: 15358368 [TBL] [Abstract][Full Text] [Related]
9. A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease. Kallenberger BC; Love JD; Chatterjee VK; Schwabe JW Nat Struct Biol; 2003 Feb; 10(2):136-40. PubMed ID: 12536206 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells. Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480 [TBL] [Abstract][Full Text] [Related]
12. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators. Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031 [TBL] [Abstract][Full Text] [Related]
13. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Han S; Inoue H; Flowers LC; Sidell N Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539 [TBL] [Abstract][Full Text] [Related]
14. Stabilization of peroxisome proliferator-activated receptor alpha by the ligand. Hirotani M; Tsukamoto T; Bourdeaux J; Sadano H; Osumi T Biochem Biophys Res Commun; 2001 Oct; 288(1):106-10. PubMed ID: 11594759 [TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor. Burendahl S; Treuter E; Nilsson L Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128 [TBL] [Abstract][Full Text] [Related]
16. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA. Valentine ER; Palmer AG Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951 [TBL] [Abstract][Full Text] [Related]
17. NMR solution structure of the inserted domain of human leukocyte function associated antigen-1. Legge GB; Kriwacki RW; Chung J; Hommel U; Ramage P; Case DA; Dyson HJ; Wright PE J Mol Biol; 2000 Feb; 295(5):1251-64. PubMed ID: 10653701 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state. Mayer ML; Olson R; Gouaux E J Mol Biol; 2001 Aug; 311(4):815-36. PubMed ID: 11518533 [TBL] [Abstract][Full Text] [Related]
19. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Germain P; Iyer J; Zechel C; Gronemeyer H Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839 [TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulation of the ligand binding domain of farnesoid X receptor. Insights into helix-12 stability and coactivator peptide stabilization in response to agonist binding. Costantino G; Entrena-Guadix A; Macchiarulo A; Gioiello A; Pellicciari R J Med Chem; 2005 May; 48(9):3251-9. PubMed ID: 15857131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]